1-168542093-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_003175.4(XCL2):c.76G>A(p.Val26Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000327 in 1,524,990 control chromosomes in the GnomAD database, including 39 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. V26V) has been classified as Likely benign.
Frequency
Consequence
NM_003175.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
XCL2 | NM_003175.4 | c.76G>A | p.Val26Ile | missense_variant | 2/3 | ENST00000367819.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
XCL2 | ENST00000367819.3 | c.76G>A | p.Val26Ile | missense_variant | 2/3 | 1 | NM_003175.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000272 AC: 40AN: 146814Hom.: 0 Cov.: 28
GnomAD3 exomes AF: 0.000640 AC: 139AN: 217224Hom.: 13 AF XY: 0.000653 AC XY: 77AN XY: 117950
GnomAD4 exome AF: 0.000333 AC: 459AN: 1378064Hom.: 39 Cov.: 30 AF XY: 0.000372 AC XY: 255AN XY: 684634
GnomAD4 genome AF: 0.000272 AC: 40AN: 146926Hom.: 0 Cov.: 28 AF XY: 0.000238 AC XY: 17AN XY: 71326
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 18, 2021 | The c.76G>A (p.V26I) alteration is located in exon 2 (coding exon 2) of the XCL2 gene. This alteration results from a G to A substitution at nucleotide position 76, causing the valine (V) at amino acid position 26 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at